Inflammatix

Medical Devices & EquipmentSeries ESunnyvale, USinflammatix.com

Latest round

Series E

Last raised

Sep 2024

Total raised

$191M

Investors

10

About Inflammatix

D., and Jonathan Romanowsky, Inflammatix, Inc. operates as a provider of immune system-based diagnostic tests to assist healthcare professionals in determining the presence and severity of infections or sepsis in patients requiring emergency care. In September 2024, Inflammatix, Inc. The company provides a wide range of diagnostic solutions, such as the TriVerity Acute Infection and Sepsis Test, which helps physicians distinguish between bacterial and viral infections and evaluate the need for ICU-level interventions. Further, the firm also provides advanced bioinformatics services leveraging machine learning and artificial intelligence for improved clinical decision-making. Additionally, the company also develops products such as the Myrna device, focusing on improving clinical decision-making through advanced immune response analysis.

Who invested in Inflammatix

10 investors across 5 rounds

See all investors in Inflammatix

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Sep 12, 2024

    Amount

    $57M

    Investors

    Locked

  2. Series D

    Mar 15, 2021

    Amount

    $102M

    Investors

    Locked

  3. Series C

    Jan 9, 2020

    Amount

    $32M

    Investors

    Locked

  4. Series B

    Oct 18, 2018

    Amount

    Undisclosed

    Investors

    Locked

  5. Series A

    Mar 17, 2017

    Amount

    Undisclosed

    Investors

    Locked

Questions about Inflammatix

Who invested in Inflammatix?

Inflammatix has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Inflammatix raised?

Inflammatix has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Inflammatix last raise money?

Inflammatix's most recent round on record is a Series E, in Sep 2024.

What does Inflammatix do?

Inflammatix is a medical devices & equipment company.

Where is Inflammatix headquartered?

Inflammatix is headquartered in Sunnyvale, US.

Which VCs invest in companies like Inflammatix?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Inflammatix's stage. Their profiles are linked below.

Raising like Inflammatix? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.